Patient-Focused Drug Development: From Concept to Reality

3:00 PM - 4:00 PM, Wednesday, June 5,2019 ・ 111AB, Level 100
Increased patient engagement in medicine development and regulatory approval decisions is occurring at a time when stakeholders - companies, patient groups and regulators - are formalizing the processes and considerations for this engagement. This session highlights efforts to build a framework and standard for patient engagement with an eye toward advancing an approach that facilitates drug development across the medicine lifecycle, including how the stakeholders are preparing to generate and use patient experience data when developing medicines, approving applications and in support of marketed medicines.
Moderator
photo
Vice President, Strategic Initiatives
National Health Council
Speakers
photo
Senior Director, Regulatory Science & Policy
Sanofi
photo
Vice President, Strategic Initiatives
National Health Council
photo
Sr Research Analyst
FDA
photo
Scientific Officer
European Medicines Agency